{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:34:05Z","timestamp":1790804045343,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100022115","name":"Dutch Arthritis Association","doi-asserted-by":"publisher","award":["2013-2-066"],"award-info":[{"award-number":["2013-2-066"]}],"id":[{"id":"10.13039\/501100022115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jaut.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:27Z","timestamp":1491436827000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["FcRL4+ B-cells in salivary glands of primary Sj\u00f6gren's syndrome patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Erlin A.","family":"Haacke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K.L.","family":"Spijkervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Vissink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G.M.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.03.012_bib1","first-page":"1","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jaut.2017.03.012_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.03.012_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s004280050347","article-title":"Lymphoepithelial duct lesions in Sj\u00f6gren-type sialadenitis","volume":"434","author":"Ihrler","year":"1999","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jaut.2017.03.012_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kel266","article-title":"Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome","volume":"46","author":"Pijpe","year":"2007","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.03.012_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.03.012_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1586\/1744666X.2014.872986","article-title":"Predicting progression to lymphoma in Sj\u00f6gren\u2019s syndrome patients","volume":"10","author":"Giannouli","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.03.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sj\u00f6gren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Med. Baltim."},{"key":"10.1016\/j.jaut.2017.03.012_bib8","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.03.012_bib9","series-title":"Extranodal Lymphomas","author":"Isaacson","year":"1994"},{"key":"10.1016\/j.jaut.2017.03.012_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jcp.2005.031146","article-title":"Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists","volume":"60","author":"Bacon","year":"2007","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.jaut.2017.03.012_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jaut.2017.03.012_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1568-9972(03)00102-2","article-title":"Lymphoproliferative disorders in Sj\u00f6gren\u2019s syndrome","volume":"3","author":"Masaki","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.03.012_bib13","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-03-0750","article-title":"Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT)","volume":"102","author":"Falini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.03.012_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20050879","article-title":"Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells","volume":"202","author":"Ehrhardt","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.03.012_bib15","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.1102651","article-title":"Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG","volume":"188","author":"Wilson","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.03.012_bib16","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1182\/blood-2011-05-353102","article-title":"FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling","volume":"118","author":"Sohn","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.03.012_bib17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2013-204116","article-title":"Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis","volume":"74","author":"Yeo","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.03.012_bib18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.03.012_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/annrheumdis-2015-208304","article-title":"Towards personalised treatment in primary Sj\u00f6gren\u2019s syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment","volume":"75","author":"Delli","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.03.012_bib20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sj\u00f6gren\u2019s syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.03.012_bib21","first-page":"317","article-title":"Abatacept treatment of patients with primary Sj\u00f6gren\u2019s syndrome results in a decrease of germinal centres in salivary gland tissue","volume":"35","author":"Haacke","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.03.012_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sj\u00f6gren\u2019s syndrome in labial salivary gland biopsies","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.jaut.2017.03.012_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/37.7.779","article-title":"Chemokine expression and leucocyte infiltration in Sj\u00f6gren\u2019s syndrome","volume":"37","author":"Cuello","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2017.03.012_bib24","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20072682","article-title":"Discriminating gene expression profiles of memory B cell subpopulations","volume":"205","author":"Ehrhardt","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.03.012_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2012.01.016","article-title":"Role of Toll-like receptors in primary Sj\u00f6gren\u2019s syndrome with a special emphasis on B-cell maturation within exocrine tissues","volume":"39","author":"Guerrier","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.03.012_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.tripleo.2010.01.006","article-title":"Expression of Toll-like receptors 7, 8, and 9 in primary Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Zheng","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.jaut.2017.03.012_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","article-title":"Modes of epithelial cell death and repair in Sj\u00f6gren\u2019s syndrome (SS)","volume":"114","author":"Polihronis","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.03.012_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.03.012_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes-key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2017.03.012_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-pathol-011811-120905","article-title":"The life and death of epithelia during inflammation: lessons learned from the gut","volume":"7","author":"Koch","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jaut.2017.03.012_bib31","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.24903","article-title":"Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Pijpe","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.03.012_bib32","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.oooo.2012.07.481","article-title":"MALT lymphoma in labial salivary gland biopsy from Sj\u00f6gren syndrome: importance of follow-up in early detection","volume":"115","author":"Keszler","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.jaut.2017.03.012_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm1566","article-title":"Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium","volume":"13","author":"Matsumoto","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.03.012_bib34","doi-asserted-by":"crossref","unstructured":"R. Kumar, L.J. DiMenna, J. Chaudhuri, T. Evans, Biological function of activation-induced cytidine deaminase (AID)., Biomed. J.. 37 269\u2013283.","DOI":"10.4103\/2319-4170.128734"},{"key":"10.1016\/j.jaut.2017.03.012_bib35","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jaut.2017.03.012_bib36","first-page":"218","article-title":"Clinical staging classification of non-Hodgkin\u2019s lymphomas (author's transl)","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:47Z","timestamp":1760256947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117301002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":36,"alternative-id":["S0896841117301002"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.03.012","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FcRL4+ B-cells in salivary glands of primary Sj\u00f6gren's syndrome patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}